Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.

Highlights
Millie raises $12M Series A to scale its tech-enabled maternity care model.
Indian women’s health brand Nua raises $4.2M in pre-series C round.
Prickly Pear Health raises $250K pre-seed for its menopause brain health platform.
Cosette Pharmaceuticals to acquire Mayne Pharma for $430M accelerating impact in women’s health and dermatology.
Daré Bioscience and Theramex partner to develop biodegradable contraceptive implant.
HeraMED partners with Garmin Health to advance remote pregnancy monitoring.
FDA approves first hormone-free copper IUD in over 40 Years from Sebela Women’s Health.
Hims & Hers enters at-home lab testing market with acquisition of Trybe Labs.
Kaia Health partners with Vira Health to deliver digital pelvic floor therapy and menopause support.
Sheba Medical Center and Nuvo partner to develop AI-powered remote pregnancy monitoring solutions.
Fertility platform Future Family launches new IVF insurance program.
Hybrid women’s health care provider HerMD to close all locations in March 2025.
Wellcome Leap launches $50M program to reduce women’s Alzheimer Risk.
UK’s SBRI Healthcare awards £1.3M to 14 women’s health innovations.
Solarea Bio is to launch medical foods for postmenopausal bone loss.
PeriGen‘s AI-powered fetal monitoring system receives FDA clearance for use from 32 weeks.
NaturalX launches €100M fund for European consumer health startups.
In the Know
The Women’s Health Goldrush: Sales over Science? (Femtech Insider)
From Data Science to Women’s Sport: How Wild.AI‘s Founder Is Challenging Gender Biases on LinkedIn and Beyond (Femtech Insider)
The fertility crash comes down to what men are doing – or not doing – Nobel laureate says (Fortune)
Femtech: 2025 Market Snapshot (PitchBook)
Why Do Women LIve Longer Than Men? (New York Times)
When Endometriosis Causes Mental Illness (Think Global Health)
Can You Sell Sexual Wellness Without Sex? (Business of Fashion)
The Teen-Disengagement Crisis (The Atlantic)
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and taming a runaway bureaucracy (Fortune)
Who’s Hiring?
Below are some jobs we’ve curated for the women’s health innovation community this week.
Tia is looking for a Director, Lifestyle Marketing.
Planned Parenthood is hiring a Press Officer, Advocacy & Health Communications
Mayne Pharma is looking for an Associate Director, Drug Safety Operations & Compliance.
Twentyeight Health is hiring a Senior Product Manager.
Millie is hiring a Head of Strategic Operations.
Everly Health is looking for a Clinical Program & Content Development Specialist.
March of Dimes is looking for an Executive Director, Market Impact.